# Associations of flavonoid intakes with metabolic dysfunction-associated steatotic liver disease in US adults

**Authors:** Yuwei He, Yu Chang, Xiangliang Liu, Yuguang Li, Wei Ji, Zhenyu Wang, Jiuwei Cui

PMC · DOI: 10.1371/journal.pone.0322797 · PLOS One · 2025-05-29

## TL;DR

Higher intake of flavonoids and specific subclasses is linked to lower odds of developing metabolic dysfunction-associated steatotic liver disease in US adults.

## Contribution

This study identifies specific flavonoid subclasses associated with reduced MASLD risk using large-scale dietary and health data.

## Key findings

- Higher total flavonoid intake was linked to 31–34% lower odds of MASLD in fully adjusted models.
- Flavan-3-ols, Flavonones, and Isoflavones showed significant inverse associations with MASLD risk.
- A non-linear dose-response relationship was found between total flavonoids and MASLD risk.

## Abstract

The incidence of Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising annually. Dietary intervention is a cornerstone of MASLD management. Flavonoids, which have anti-inflammatory properties, are thought to benefit MASLD. Using data from the National Health and Nutrition Examination Survey (NHANES) from 2007–2010 and 2017–2018, we conducted a large cross-sectional study. Weighted Logistic regression, Restricted Cubic Spline (RCS) models, and Weighted Quantile Sum (WQS) regressions were used to explore the relationship between Total flavonoid and subclass (Flavones, Flavan-3-ols, Flavonols, Flavonones, Isoflavones, Anthocyanins) intake and MASLD. Participants in the higher tertiles of Total flavonoids intake had 31–34% lower odds of MASLD compared to the lowest tertile intake in the fully adjusted models (Tertile2: OR 0.69, 95%CI 0.55–0.86, P = 0.002, Tertile 3: OR 0.66, 95%CI 0.52–0.84, P < 0.001). Increased intakes of Flavan-3-ols (Tertile 2 in Model 2: OR 0.65, 95%CI 0.49–0.87, P = 0.01), Flavanones (Tertile 3 in Model 2: OR 0.70, 95%CI 0.53–0.91, P = 0.01), and Isoflavones (Tertile 3 in Model 2: OR 0.65, 95%CI 0.52–0.83, P < 0.001) were significantly associated with 30–35% decreased odds of having MASLD. The RCS revealed a significant non-linear dose-response relationship between Total flavonoid, flavonols and MASLD. The WQS model showed that Flavones and Isoflavones had the largest negative contributions to MASLD risk. Our study demontrated a negative correlation between Total flavonoids and their subclasses and risk of MASLD, highlighting the importance of increasing dietary flavonoid intake in the prevention and treatment of MASLD.

## Linked entities

- **Chemicals:** Flavonols (PubChem CID 11349), Isoflavones (PubChem CID 72304), Anthocyanins (PubChem CID 145858)
- **Diseases:** Metabolic dysfunction-associated steatotic liver disease (MONDO:0013209), MASLD (MONDO:0013209)

## Full-text entities

- **Diseases:** MASLD (MESH:D008107), inflammatory (MESH:D007249)
- **Chemicals:** Flavonoids (MESH:D005419), Flavonols (MESH:D044948), Flavan-3-ols (MESH:C404987), Flavones (MESH:D047309), Isoflavones (MESH:D007529), Flavonones (-), Anthocyanins (MESH:D000872)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12121751/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12121751/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12121751/full.md

---
Source: https://tomesphere.com/paper/PMC12121751